SEROCONVERSION in Slovenian translation

• serokonverzija
• serokonverzije
• serološke konverzije
• serokonverzijo
• serokonverziji
• faktor serokonverzije

Examples of using Seroconversion in English and their translations into Slovenian

The net effect of these changes after seroconversion was an increase in exposure of 2- to 3-fold based on AUC and Cmax.
Neto učinek teh sprememb po serokonverziji je bila 2 do 3 krat večji po izpostavljenosti glede na AUC in Cmax.

treatment should be administered at least until HBs seroconversion or there is evidence of loss of efficacy.
bolnikih brez ciroze naj zdravljenje traja najmanj do HBs serokonverzije ali do dokazane izgube učinkovitosti.

No unexpected safety issues were encountered in patients with an increase in exposure after seroconversion.
Pri bolnikih s povečano izpostavljenostjo po serokonverziji ni prišlo do nepričakovanih spornih varnostnih vprašanj.

treatment should be administered at least until HBs seroconversion or there is evidence of loss of efficacy.
bolnikih s CHB brez ciroze je treba zdravljenje nadaljevati vsaj do HBs serokonverzije ali do pojava znakov izgube učinkovitosti.

The seroprotection rate*, seroconversion rate* and the seroconversion factor** for anti-HA antibody to H5N1 A/Vietnam/1194/2004 in the adults measured by SRH assay was as follows.
Stopnja serozaščite*, deleţ serokonverzije* in faktor serokonverzije** za protitelo proti HA na H5N1 A/Vietnam/1194/2004 pri odraslih, izmerjeno s testom SRH, so bili kot sledi.

The seroprotection rate*, seroconversion rate* and the seroconversion factor** for anti-HA antibody to H5N1 A/Vietnam/1194/2004 measured by SRH assays were as follows.
Miera séroprotekcie*, miera sérokonverzie* a faktor sérokonverzie** pre anti-HA protilátku voči H5N1 A/Vietnam/1194/2004 merané SRH analýzou boli nasledujúce.

If an HIV antibody test is done before seroconversion is complete then it may not be positive.
Če sepreskus HIV storiti, preden serološke je popolna, potem morda ne pokažejo še pozitivna.

The seroprotection rate, seroconversion rate and seroconversion factor for anti-HA antibody as measured by single radial haemolysis(SRH)
Odstotek serozaščite, odstotek serokonverzije in faktor serokonverzije, izmerjeni z enkratno radialno hemolizo(SRH) za protitelesa proti HA po cepljenju otrok,

The seroprotection rate*, seroconversion rate* and the seroconversion factor** for anti-HA antibody in subjects aged over 60 measured by SRH were as follows.
Stopnja serološke zaščite*, stopnja serološke konverzije* in faktor serološke konverzije** izmerjeni s SRH za protitelesa proti HA, so bili pri starejših od 60 let naslednji.

after each half-dose(0.25 ml) of HUMENZA in term of the seroprotection rate, the seroconversion rate and the seroconversion factor, using HI method, were as follows.
cepiva HUMENZA v smislu deleža serozaščite, deleža serokonverzije in faktorja serokonverzije po metodi HI so bili sledeči.

The seroprotection rate*, seroconversion rate* and the seroconversion factor** for anti-HA antibody to H5N1 A/Vietnam/1194/2004 in the adults measured by Single Radial Haemolysis(SRH) assay was as follows.
Stopnja serozaščite*, delež serokonverzije* in faktor serokonverzije** za protitelo proti HA na H5N1 A/Vietnam/1194/2004 pri odraslih, izmerjeni s testom enkratne radialne hemolize(SRH- single radial haemolysis), so bili, kot sledi.

Months after HBe seroconversion(HBeAg loss and HBV DNA loss with anti-HBe detection) is confirmed or until HBs seroconversion or there is loss of efficacy(see section 4.4).
Potrditvi HBe serološke konverzije(izguba HBeAg in izguba HBV DNA z detekcijo anti- HBe) ali do HBs serološke konverzije ali dokler ne pride do izgube učinkovitosti(glejte poglavje 4. 4).

HBeAg seroconversion was increased in patients with elevated ALT levels;
Pri bolnikih s povečanimi vrednostmi ALT se je serokonverzija HBeAg povečala;

In this comparative trial the seroprotection rate*, seroconversion or significant increase rate** and the geometric mean titre ratio(GMTR)
V tem primerjalnem preskušanju so ocenili stopnjo serozaščite*, serokonverzijo ali značilne stopnje povečanja** in razmerje geometričnega povprečja titrov(GMTR)

sustained HBeAg seroconversion(79.2%; 19/24).
kot HBeAg serokonverzija(pri 79,2%;19/24).

hepatitis B vaccines were administered concomitantly with specific immunoglobulins, no influence on seroconversion was observed although it may result in lower antibody titres.
hepatitisu B dani hkrati s specifičnimi imunoglobulini, ni bilo opaziti vpliva na serokonverzijo, čeprav so titri protiteles lahko nižji.

26% for HBeAg seroconversion, and 2% for HBsAg seroconversion(3% for HBsAg loss).
26% za serokonverzijo HBeAg in 2% za serokonverzijo HBsAg(3% za izginotje HBsAg).

Telbivudine-treated patients who achieved PCR negativity by week 24 had the highest rates of PCR negativity and HBeAg seroconversion(in HBeAg-positive patients),
Bolniki, ki so prejemali telbivudin in so po 24 tednih dosegli negativnost testa PCR, so po 104 tednih dosegli najvišja deleža negativnosti in HBeAg serokonverzije(pri HBeAg- pozitivnih bolnikih)

Telbivudine-treated patients who achieved undetectable HBV DNA by PCR by week 24 had the highest rates of HBV DNA undetectability and HBeAg seroconversion(in HBeAg-positive patients),
Bolniki, ki so prejemali telbivudin in so po 24 tednih dosegli nemerljive vrednosti HBV DNA pri testu PCR, so po 104 tednih dosegli najvišja deleža nemerljivosti HBV DNA in HBeAg serokonverzije(pri HBeAg-pozitivnih bolnikih)

39% achieved HBeAg seroconversion, 90% achieved ALT normalisation at week 52
39% jih je doseglo HBeAg serokonverzijo, 90% normalizacijo ALT, po koncu 48. tedna